- June 21, 2018
-
Ohara has entered into license agreement with PRISM on novel liver cirrhosis treatment (PDF: 116KB)
- September 13, 2017
-
A Cooperative Research Study with the National Cancer Center Japan (PDF: 1.03MB)
- February 14, 2017
-
Postponement of the NHI Drug Price Listing and Launch of "ERWINASE® for intramuscular injection 10000" (PDF: 129KB)
- December 19, 2016
-
Acquisition of Marketing Approval in Japan for "ERWINASE® for intramuscular injection 10000" (PDF: 168KB)
- March 15, 2016
